Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Hyperthermia ; 26(6): 586-93, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20569109

RESUMO

PURPOSE: To elucidate the causation mechanism of Spectral Doppler ultrasound signals (DUS) observed during high temperature thermal ablation and evaluate their potential for image-guidance. METHODS: Sixteen ex vivo ablations were performed in fresh turkey breast muscle, eight with radiofrequency ablation (RFA) devices, and eight with a conductive interstitial thermal therapy (CITT) device. Temperature changes in the ablation zone were measured with thermocouples located at 1 to 10 mm away from the ablation probes. Concomitantly, DUS were recorded using a standard diagnostic ultrasound scanner. Retrospectively, sustained observations of DUS were correlated with measured temperatures. Sustained DUS was arbitrarily defined as the Doppler signals lasting more than 10 s as observed in the diagnostic ultrasound videos captured from the scanner. RESULTS: For RFA experiments, minimum average temperature (T1 +/- SD) at which sustained DUS were observed was 97.2 +/- 7.3 degrees C, while the maximum average temperature (T2 +/- SD) at which DUS were not seen was 74.3 +/- 9.1 degrees C. For CITT ablation, T1 and T2 were 95.7 +/- 5.9 degrees C and 91.6 +/- 7.2 degrees C, respectively. It was also observed, especially during CITT ablation, that temperatures remained relatively constant during Doppler activity. CONCLUSIONS: The value of T1 was near the standard boiling point of water (99.61 degrees C) while T2 was below it. Together, T1 and T2 support the conclusion that DUS during high temperature thermal ablation are the result of boiling (phase change). This conclusion is also supported by the nearly constant temperature histories maintained at locations from which DUS emanated.


Assuntos
Ablação por Cateter , Temperatura Alta , Músculo Esquelético/fisiopatologia , Temperatura de Transição , Ultrassonografia Doppler , Animais , Hipertermia Induzida , Modelos Animais , Músculo Esquelético/cirurgia , Temperatura , Condutividade Térmica , Turquia
2.
Phys Med Biol ; 53(10): 2509-22, 2008 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-18424880

RESUMO

Simultaneous thermoradiotherapy has been shown to maximize the effect of hyperthermia as a radiation sensitizer in cancer treatment. Here we follow our previous work on feasibility of thermoradiotherapy with the scanning ultrasound reflector linear array system (SURLAS) and TomoTherapy HiArt treatment system, and investigate the influence of the SURLAS hyperthermia applicator on delivered radiation dose with the TomoTherapy. A radiation treatment plan was calculated and the treatment was delivered to a phantom with SURLAS on top simulating the likely clinical setup. Proper positioning of the SURLAS was assisted with a magnetic position-and-orientation tracking device (POTD) and was verified with megavoltage-computed tomography. The delivered dose was measured with an ionization chamber (point measurement) and a radiographic film (2D dose distributions). The planned and delivered point dose data agreed within 0.61% +/- 0.63%. Planar dose data agreed within a dose difference of < or =3% of the maximum dose, and a distance-to-dose-agreement of < or =1 mm. The susceptibility of the delivered radiation dose on correct SURLAS positioning was studied as well. The largest dose discrepancy was measured for a position for which a maximum number of radiation beams intersected the incorrectly positioned SURLAS within one TomoTherapy gantry rotation. The point dose disagreed by 6.14% +/- 0.52%, and 2.25% of pixels of the 2D dose distribution did not pass the 3% dose difference/1 mm distance-to-dose-agreement criteria. Our study showed that correct positioning of the SURLAS applicator had an influence on the delivered radiation dose. Delivered and planned dose distributions were in an excellent agreement when SURLAS was positioned according to the treatment plan. Moving the applicator from its planned position was found to cause a modification of delivered dose distributions. A precise and reproducible positioning of the applicator was assured with a POTD.


Assuntos
Hipertermia Induzida/métodos , Doses de Radiação , Radioterapia/métodos , Humanos , Hipertermia Induzida/instrumentação , Metais , Imagens de Fantasmas , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Fatores de Tempo , Tomografia Computadorizada por Raios X , Terapia por Ultrassom/instrumentação , Terapia por Ultrassom/métodos
3.
Ultrasound Med Biol ; 33(8): 1285-95, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17490808

RESUMO

Ultrasound thermal effects have been hypothesized to contribute to ultrasound-assisted thrombolysis. To explore the thermal mechanism of ultrasound-enhanced thrombolysis with recombinant tissue plasminogen activator (rt-PA) for the treatment of ischemic stroke, a detailed investigation is needed of the heating produced in skull, brain and blood clots. A theoretical model is developed to provide an estimate for the worst-case scenario of the temperature increase in blood clots and on the surface of cranial bone exposed to 0.12- to 3.5-MHz ultrasound. Thermal elevation was also assessed experimentally in human temporal bone, human clots and porcine clots exposed to 0.12 to 3.5-MHz pulsed ultrasound in vitro with a peak-to-peak pressure of 0.25 MPa and 80% duty cycle. Blood clots exposed to 0.12-MHz pulsed ultrasound exhibited a small temperature increase (0.25 degrees C) and bone exposed to 1.0-MHz pulsed ultrasound exhibited the highest temperature increase (1.0 degrees C). These experimental results were compared with the predicted temperature elevations.


Assuntos
Acidente Vascular Cerebral/terapia , Osso Temporal/fisiologia , Terapia Trombolítica , Ativador de Plasminogênio Tecidual/uso terapêutico , Terapia por Ultrassom , Animais , Coagulação Sanguínea , Terapia Combinada , Calefação , Humanos , Técnicas In Vitro , Modelos Biológicos , Proteínas Recombinantes/uso terapêutico , Sus scrofa , Temperatura
4.
J Acoust Soc Am ; 119(6): 3766-72, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16838520

RESUMO

The efficacy of ultrasound-assisted thrombolysis as an adjunct treatment of ischemic stroke is being widely investigated. To determine the role of ultrasound hyperthermia in the process of blood clot disruption, the acousto-mechanical and thermal properties of clotted blood were measured in vitro, namely, density, speed of sound, frequency-dependent attenuation, specific heat, and thermal conductivity. The amplitude coefficient of attenuation of the clots was determined for 120 kHz, 1.0 MHz, and 3.5 MHz ultrasound at room temperature (20 +/- 2 degrees C). The attenuation coefficient ranged from 0.10 to 0.30 Np/cm in porcine clots and from 0.09 to 0.23 Np/cm in human clots. The experimentally determined values of specific heat and thermal conductivity for porcine clotted blood are (3.2 +/- 0.5) x 10(3) J/kg x K and 0.55 +/- 0.13 W/m x K, respectively, and for human clotted blood are (3.5 +/- 0.8) x 10(3) J/kg x K and 0.59 +/- 0.11 W/m x K, respectively. Measurements of the acousto-mechanical and thermal properties of clotted blood can be helpful in theoretical modeling of ultrasound hyperthermia in ultrasound-assisted thrombolysis and other high-intensity focused ultrasound applications.


Assuntos
Coagulação Sanguínea/fisiologia , Animais , Calorimetria , Densitometria , Fibrinólise/fisiologia , Fibrinolíticos/uso terapêutico , Temperatura Alta , Humanos , Modelos Biológicos , Proteínas Recombinantes/uso terapêutico , Acidente Vascular Cerebral/sangue , Acidente Vascular Cerebral/terapia , Suínos , Condutividade Térmica , Terapia Trombolítica/métodos , Ativador de Plasminogênio Tecidual/genética , Ativador de Plasminogênio Tecidual/uso terapêutico , Terapia por Ultrassom
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA